Close Menu
Home » Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

Celsee, IncellDx to Commercialize Assays After Cancer Study Collaboration

Jan 11, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Celsee said today that it has entered a co-commercialization agreement with IncellDx for several products, including a 20-marker lung cancer genomics and proteomics panel, a CTC-based screening test for breast, colorectal, prostate, and other cancers, and a cell-based NIPT assay.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Holden Thorp to Take Over at Science

Holden Thorp is to be the new editor-in-chief of Science and its related journals.

Fewer Fish in the River

A genetic analysis of salmon scales collected over the course of a century points to a sharp decline in the number of fish returning each year to river in British Columbia, CBC reports.

Ancient DNA Lab Head Suspended During Workplace Culture Review

Adelaide University has suspended the head of an ancient DNA lab as its investigation of workplace bullying continues, Australia's ABC News reports.

PNAS Studies Describe Adipocyte Subtypes, Plant Expressome Analysis, More

In PNAS this week: gene expression profiles of adipocyte subtypes, computational approach for improving plant expressome analysis, and more.

What's Popular?

In Business News

  1. 10x Genomics Files for $100M IPO

  2. Genomind, NeuroFlow Collaborate to Provide Genetic Testing-Based Mental Health Services

  3. Aqualung Therapeutics Wins $225K NIH Grant to Develop Respiratory Distress Biomarker Panel

  4. Genomenon Enters Chinese Market With Shanghai Shanyi Partnership

  5. Cancer Genetics Posts 15 Percent Rise in Q2 Revenues

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.